PI3 and gastric cancer: The role of drugs that target the PI3/Akt/m-TOR pathway is to restore the effectivity of chemotherapy against gastric cancer cells by inhibiting cell proliferation and supporting apoptosis (Matsuoka and Yashiro, 2014).